{"disease":{"id":"left-cardiac-catheterization","name":"left cardiac catheterization"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806633","title":"Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":1722,"lead_sponsor_name":"G.Gennimatas General Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}